Provider facility background
Suman Kambhampati, MD

Suman Kambhampati, MD

Medical Oncology
Suman Kambhampati, MD, is board-certified in Hematology/Medical Oncology. He is Co-Medical Director of the Blood Cancer Program at Sarah Cannon Cancer Institute, HCA Midwest Health located at Research Medical Center, Kansas City. Dr. Kambhampati treats patients affected by blood cancers and complex hematology issues. He has led or participated in multiple cancer research studies and published numerous professional papers. Dr. Kambhampati currently serves as Vice-Chair of the Sarah Cannon Blood Cancer Network (SCBCN) Quality Management Committee on Complex Blood Cancers and is involved with teaching and training of trainees at the Kansas City VA Medical Center, where he serves as a staff physician. He is Principal Investigator with the Southwest Oncology Group (SWOG), an affiliate of the National Cancer Institute (NCI), and leads efforts at VA to enroll patients into SWOG/NCI-sponsored clinical trials. Dr. Kambhampati has received multiple awards for both his research and patient care, including the prestigious Alpha Omega Alpha and Lauri Stauss Leukemia Foundation Research Fellow; Department of Veterans Affairs Special Contribution Awards in Clinical Practice, Research and System Redesigns; Kansas NIH COBRE First Award in Cancer Experimental Therapeutics; Kansas City Super Docs in Hematology and Oncology; Appreciation of Exceptional Leadership and Dedication to Oncology from the Association of VA Hematology and Oncology. He is a professional member of the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), the American Association for Cancer Research (AACR), and the Association of Veteran Affairs Hematology & Oncology (AVAHO), of which he served as president. He serves as board member of the Leukemia and Lymphoma Society (LLS).

Acute Leukemia

Acute Lymphocytic Leukemia

Acute Myeloid Leukemia

All Lymphoma

All Types Of Cancers

Anemia

Antiphospholipid Syndrome (APS)

Aplastic Anemia

Autoimmune Diseases

Autoimmune Hemolytic Anemia

Bleeding Disorders

Blood Cancers

Blood Disorders

Bone Disorders

Burkitt's Lymphoma

Cancer

Central Nervous System Lymphoma

Chemotherapy

Chronic Myeloid Leukemia (CML)

Coagulation Disorders (incl. Hemophilia)

Deep vein thrombosis (DVT)

Essential Thrombocytosis (Primary Thrombocythemia)

Hemophilia

Hemophilia A

Heparin-Induced Thrombocytopenia

Hodgkin's Disease

Hodgkin's Lymphoma

Hypercoagulable State

Hypercoagulable State (Hypercoagulable State)

Immune Thrombocytopenic Purpura - ITP

Iron Deficiency Anemia

Leukemia

Leukocytosis

Lymphoma

Lymphoma, Large Cell, Anaplastic

Lymphoma, Large-Cell

Lymphosarcoma

Macroglobulinemia (incl. Waldenstrom's )

Mantle Cell Lymphoma

Marginal Zone Lymphoma

Multiple Myeloma

Mycosis Fungoides

Myelodysplastic Syndrome

Myeloproliferative Disorders

Neutropenia

Nodular Lymphoma

Non-Hodgkin's Lymphoma

Pancytopenia

Pernicious Anemia

Polycythemia Rubra Vera

Polycythemia Vera

Primary Central Nervous System Lymphoma

Primary Hypercoagulable State (incl. Factor V Leiden Disease)

Purpura

Radiation Therapy

Reticulosarcoma

Sezary's Disease

Sickle Cell Anemia

Sickle Cell Disease

Stem Cell Transplant

Telemedicine

Thalassemia

Thrombocytopenia

Thrombocytosis

Thrombosis

Thrombotic Thrombocytopenic Purpura

Vascular Disease

Venous Embolism and Thrombosis

von Willebrand Disease